Articles

The microtubule-dynamin binding inhibitor peptide PHDP5 rescues spatial learning and memory deficits in Alzheimer's disease model mice

Elsevier,

Brain Research, Volume 1838, 1 September 2024

The study demonstrates that the peptide PHDP5, which inhibits dynamin-MT interaction, can rescue impaired endocytosis and synaptic transmission caused by tau in presynaptic terminals. When administered intranasally to Alzheimer's disease (AD) model mice, PHDP5 significantly improved learning and memory, suggesting its potential as a candidate for human AD therapy.
Read more

SDG:

Goal 3: Good health and well-being
Global

Neuroprotective action of hordenine against the Aluminium Chloride (AlCl<inf>3</inf>) induced Alzheimer's diseases &amp; associated memory impairment in experimental rats

Elsevier,

Pharmacological Research - Modern Chinese Medicine, Volume 12, September 2024

The study investigates the neuroprotective effects of hordenine against AlCl3-induced Alzheimer’s disease in rats. Results show that hordenine improves memory and cognitive functions, suggesting its potential to reverse oxidative stress and neuroinflammation associated with Alzheimer’s
Read more

SDG:

Goal 3: Good health and well-being
Global

A Narrative Review of Alzheimer Dementia in African American and Hispanic Populations: The Health Care Provider's Role

Elsevier,

Journal for Nurse Practitioners, Volume 20, September 2024

Nurse practitioners and other health care providers can play a crucial role in implementing chronic disease management strategies and educating patients who are at risk for AD among African Americans and Hispanics.
Read more

SDG:

Goal 3: Good health and well-being
Global

How racism plays out in contemporary public health practice (commentary)

Elsevier,

Australian and New Zealand Journal of Public Health, Volume 48, August 2024

This paper seeks to describe and categorise some of the most common behaviours and practices of public health professionals and institutions that introduce or sustain systematic ethnic bias into public health work and thus potentially perpetuate or exacerbate Indigenous inequities in health.
Read more

SDG:

Goal 10: Reduced inequalities; Goal 3: Good health and well-being; Goal 4: Quality education
Oceania

Current Developments in Alzheimer's Disease: Developments in Alzheimer's Disease

Elsevier,

The American Journal of Medicine, Available online 27 August 2024

The present mini-commentary on Alzheimer's disease describes recently revealed pathogenic elements, evolving capabilities for identifying unusually high individual susceptibility and developing tests that predict onset preclinically to allow preventative approaches. Several potential therapies that target cellular signaling and other pathways that are abnormal in Alzheimer's disease are in early clinical trials and will be reviewed briefly.

Read more

SDG:

Goal 3: Good health and well-being
North America

In the Age of AI: Highlights from RELX SDG Inspiration Day 2024

RELX

More than 1100 people came together virtually on 18 June 2024 for the tenth edition of the RELX SDG Inspiration Day: "In the Age of AI: Information to Advance the UN Sustainable Development Goals (SDGs)." The annual online event brings together thought leaders, corporate representatives, students, investors, governments, and NGOs to explore pressing issues, gain practical insight, and inspire action on the United Nations Sustainable Development Goals (SDGs).

Read more

SDG:

Goal 1: No poverty; Goal 2: Zero hunger; Goal 3: Good health and well-being; Goal 4: Quality education; Goal 5: Gender equality; Goal 6: Clean water and sanitation; Goal 7: Affordable and clean energy; Goal 8: Decent work and economic growth; Goal 9: Industry, innovation and infrastructure; Goal 10: Reduced inequalities; Goal 11: Sustainable cities and communities; Goal 12: Responsible consumption and production; Goal 13: Climate action; Goal 14: Life below water; Goal 15: Life on land; Goal 16: Peace, justice and strong institutions; Goal 17: Partnership for the goals

Tags:

Artificial Intelligence; health technology; Technology; Multi-stakeholder partnerships, Global

Lipids and carotenoids may influence the neuropathology of Alzheimer's disease: A meta-analysis

Elsevier,

Archives of Gerontology and Geriatrics Plus, Volume 1, Issue 4, December 2024, 100072

This study reveals that the estimation of lipids and carotenoid levels could support the early diagnosis or help to understand the pathophysiology of Alzheimer's Disease.

Read more

SDG:

Goal 3: Good health and well-being
Global

Meeting your ancestors – Sticks, stones, and discord in Earth's outposts

Elsevier,

Global Ecology and Conservation, Volume 52, August 2024

This paper highlights the importance for conservation biologists and on-the-ground practitioners to engage more with local pastoralists to tackle the complex and infrequently described conflicts on how best to implement protective policies.
Read more

SDG:

Goal 15: Life on land

Tags:

Biodiversity and ecosystems, Global

RELX SDG Customer Awards 2024

Image of a microscope in a laboratory
RELX

Recognising our customers' exceptional work to achieve the UN Sustainable Development Goals.

Read more

SDG:

Goal 1: No poverty; Goal 2: Zero hunger; Goal 3: Good health and well-being; Goal 4: Quality education; Goal 5: Gender equality; Goal 6: Clean water and sanitation; Goal 7: Affordable and clean energy; Goal 8: Decent work and economic growth; Goal 9: Industry, innovation and infrastructure; Goal 10: Reduced inequalities; Goal 11: Sustainable cities and communities; Goal 12: Responsible consumption and production; Goal 13: Climate action; Goal 14: Life below water; Goal 15: Life on land; Goal 16: Peace, justice and strong institutions; Goal 17: Partnership for the goals

Tags:

Sustainable Business Practices; Sustainable Development; Sustainable consumption and production, Global

Magnesium and Cognitive Health in Adults: A Systematic Review and Meta-Analysis

Elsevier,

Advances in Nutrition, Volume 15, August 2024

Dementia is a global leading cause of disability and death among older adults, and there is a need to carefully evaluate existing evidence on related risk factors to guide future research. This review summarized and evaluated the most updated evidence on associations of various magnesium forms (supplements, dietary intake, and biomarkers) with cognitive outcomes in adults, based on evidence from randomized controlled trials and cohort studies.
Read more

SDG:

Goal 3: Good health and well-being

Tags:

Health and wellbeing, Global

Pages